Erik Garcia, Assistant Professor of Psychology and Neuroscience at the University of Nebraska Omaha, will present “Sub-hallucinogenic Doses of a 5-HT2A Receptor Agonists Diminish Opioid Reinforcement: Sex and Developmental Implications” at our September Seminar Series event!

Opioid use continues to be a major public health concern. The use of translationally-relevant models of substance use can reveal the behavioral and neurobiological mechanisms that lead to uncontrolled consumption and overvaluation of drugs. This presentation will discuss the latest developments in identifying a non-opioid receptor target to suppress opioid reward and opioid value. Dr. Garcia’s latest research indicates that the serotonin 5-HT2A receptor is a viable target, but this may depend on biological sex and early life developmental environments.

Dr. Erik Garcia is a behavioral neuroscientist and neuropharmacologist. His research identifies individual-level predictors that govern the development of substance use disorders. Dr. Garcia aims to bridge the gap between preclinical discoveries and meaningful clinical outcomes to aid people in their path toward substance use recovery. Most importantly, he is a firm believer and advocate for diversity, inclusion, and mentoring scientists.

This event is FREE and OPEN to the public. Register Here: https://unl.zoom.us/webinar/register/WN_xkyfC9-pR6SfAry3jXq5zw